Advair Hfa Aerosol, Metered
Product Images NDC 50090-4504

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Advair Hfa (NDC 50090-4504). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fluticasone Chemical Structure (Advairhfa Spl Graphic 01)

Fluticasone Chemical Structure (Advairhfa Spl Graphic 01)
FDA Label Image

Salmeterol Chemical Structure (Advairhfa Spl Graphic 02)

Salmeterol Chemical Structure (Advairhfa Spl Graphic 02)
FDA Label Image

Figure 1. Mean Percent Change From Baseline In Fev1 In Subjects Previously Treated With Either Beta2 Agonists (albuterol Or Salmeterol) Or Inhaled Corticosteroids (trial 1) (Advairhfa Spl Graphic 03)

Figure 1. Mean Percent Change From Baseline In Fev1 In Subjects Previously Treated With Either Beta2 Agonists (albuterol Or Salmeterol) Or Inhaled Corticosteroids (trial 1) (Advairhfa Spl Graphic 03)
FDA Label Image

Figure 2. Mean Percent Change From Baseline In Morning Peak Expiratory Flow In Subjects Previously Treated With Inhaled Corticosteroids (trial 4) (Advairhfa Spl Graphic 04)

Figure 2. Mean Percent Change From Baseline In Morning Peak Expiratory Flow In Subjects Previously Treated With Inhaled Corticosteroids (trial 4) (Advairhfa Spl Graphic 04)
Not Available.*
FDA Label Image

Figure 3. Percent Change In Serial 12-hour Fev1 In Subjects Previously Using Either Beta2-agonists (albuterol Or Salmeterol) Or Inhaled Corticosteroids (trial 1) (Advairhfa Spl Graphic 05)

Figure 3. Percent Change In Serial 12-hour Fev1 In Subjects Previously Using Either Beta2-agonists (albuterol Or Salmeterol) Or Inhaled Corticosteroids (trial 1) (Advairhfa Spl Graphic 05)
This text appears to be a comparison of the change in FEV (Forced Expiratory Volume) between two different inhalers. One is ADVAIR HFA 45 mog/21 meg, taken twice daily by 92 participants, while the other is a combination of Fluticasone propionate inhalation aerosol 44 meg and Salmeterol inhalation aerosol 21 meg, taken twice daily by 89 participants. The change in FEV is being evaluated over a period of time, starting from Day 1 baseline.*
FDA Label Image

Figure 4. Percent Change In Serial 12-hour Fev1 In Subjects Previously Using Either Beta2-agonists (albuterol Or Salmeterol) Or Inhaled Corticosteroids (trial 1) (Advairhfa Spl Graphic 06)

Figure 4. Percent Change In Serial 12-hour Fev1 In Subjects Previously Using Either Beta2-agonists (albuterol Or Salmeterol) Or Inhaled Corticosteroids (trial 1) (Advairhfa Spl Graphic 06)
FDA Label Image

Figure A (Advairhfa Spl Graphic 07)

Figure A (Advairhfa Spl Graphic 07)
FDA Label Image

Figure B (Advairhfa Spl Graphic 08)

Figure B (Advairhfa Spl Graphic 08)
FDA Label Image

Figure C (Advairhfa Spl Graphic 09)

Figure C (Advairhfa Spl Graphic 09)
FDA Label Image

Figure D (Advairhfa Spl Graphic 10)

Figure D (Advairhfa Spl Graphic 10)
FDA Label Image

Figure E (Advairhfa Spl Graphic 11)

Figure E (Advairhfa Spl Graphic 11)
FDA Label Image

Figure F (Advairhfa Spl Graphic 12)

Figure F (Advairhfa Spl Graphic 12)
FDA Label Image

Figure G (Advairhfa Spl Graphic 13)

Figure G (Advairhfa Spl Graphic 13)
FDA Label Image

Figure H (Advairhfa Spl Graphic 14)

Figure H (Advairhfa Spl Graphic 14)
FDA Label Image

Figure I (Advairhfa Spl Graphic 15)

Figure I (Advairhfa Spl Graphic 15)
FDA Label Image

Figure J (Advairhfa Spl Graphic 16)

Figure J (Advairhfa Spl Graphic 16)
FDA Label Image

Label Image (Lbl500904504)

Label Image (Lbl500904504)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.